Lab Medical Group provides you with full comprehensive toxicology testing of over 140 medications with custom panels available, with results in 24 hours from when our lab receives samples. Supports the Clinician’s medication treatment process by identifying recent use of prescribed drugs and other illicit substances.
- Reduces risk of regulatory agency scrutiny and investigation by documenting that the physician is monitoring and evaluating prescribed medications.
- Provides measurements that objectify pharmacotherapeutic regimens for reporting to workers’ compensation boards, medical boards, insurance providers, DEA, and other regulatory agencies.
- Assists in complying with DEA’s current Interim Policy Statement which requires doctors to minimize the potential for abuse and diversion.
- Assists in complying with The Federation of State Medical Board’s “Model Policy for the Use of Controlled Substances for the Treatment of Pain” which suggests in part that the medical records of patients contain “diagnostic, therapeutic and laboratory results” and further suggests extra care and monitoring of patients with a history of substance abuse.
Substance Abuse, Misuse, Diversion and Addiction / Pseudoaddiction Issues
- Provides the clinician with an objective test which documents prescription drug misuse and/or illicit drug usage. The patient may be required to write an
explanation for any inaccuracies in drug test.
- May assist in the verification of patient historical data including: suspicious stories, family reports of abuse, in office written explanation of relapse, etc.
- May confirm behavioral observations including: continued risky behavior, missed appointment(s), intoxicated appearance, pill count discrepancies, early
refill requests, and pharmacy calls/concerns.
- May identify intentional dilution, adulteration, substitution or tampering with the specimen.
- Supports referral for treatment to a substance abuse professional.
- Allows the clinician to monitor drug elimination of discontinued illicit or prescription medication.
- Imposes a barrier for patient’s intent on diverting opioid medication.
- Identifies the use of illicit substances throughout the treatment process and assists in making the appropriate decisions regarding discontinuation of medication/treatment and referral to the appropriate addiction and/or mental health professional.
- Reduces the risk of therapeutic failure by detecting noncompliant patients.
- Confirms compliance with the agreed upon treatment plan.